Liquid Dosage Forms to Treat Cancer
- 专利权人:
- Exelixis; Inc.
- 发明人:
- Khalid Shah,Gisela Schwab,Steven Lacy
- 申请号：
- US16620379
- 公开号：
- US20200268737A1
- 申请日:
- 2018.06.08
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- This invention relates to a liquid pharmaceutical composition comprising cabozantinib to treat locally advanced or metastatic solid tumors, particularly advanced urothelial cancer or renal cell carcinoma in patients in need thereof.
- 来源网站：
- 中国工程科技知识中心
